Your browser doesn't support javascript.
loading
Fluorodeoxyglucose positron emission tomography/magnetic resonance imaging: current status, future aspects.
Rakheja, Rajan; Chandarana, Hersh; Ponzo, Fabio; Seltzer, Alexandra L; Beltran, Luis S; Geppert, Christian; Friedman, Kent P.
Afiliação
  • Rakheja R; Department of Nuclear Medicine/Radiology, Royal University Hospital, Saskatoon, Saskatchewan, Canada. Electronic address: rajan.rakheja@gmail.com.
  • Chandarana H; Department of Radiology, New York University School of Medicine, 550 First Avenue, New York, NY, USA.
  • Ponzo F; Department of Radiology, New York University School of Medicine, 550 First Avenue, New York, NY, USA.
  • Seltzer AL; Department of Radiology, New York University School of Medicine, 550 First Avenue, New York, NY, USA.
  • Beltran LS; Department of Radiology, New York University School of Medicine, 550 First Avenue, New York, NY, USA.
  • Geppert C; MR R&D Collaborations, Siemens Healthcare, New York, NY, USA.
  • Friedman KP; Department of Radiology, New York University School of Medicine, 550 First Avenue, New York, NY, USA.
PET Clin ; 9(2): 237-52, 2014 Apr.
Article em En | MEDLINE | ID: mdl-25030285
ABSTRACT
Simultaneous positron emission tomography (PET)/magnetic resonance (MR) imaging is a promising novel technology for oncology diagnosis and staging and neurologic and cardiac applications. Our institution's current research protocol results in a total imaging time of approximately 45 to 70 minutes with simultaneous PET/MR imaging, making this a feasible total body imaging protocol. Further development of MR-based attenuation correction will improve PET quantification. Quantitatively accurate multiparametric PET/MR data sets will likely improve diagnosis of disease and help guide and monitor the therapies for individualized patient care.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imageamento por Ressonância Magnética / Compostos Radiofarmacêuticos / Fluordesoxiglucose F18 / Tomografia por Emissão de Pósitrons / Imagem Multimodal Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imageamento por Ressonância Magnética / Compostos Radiofarmacêuticos / Fluordesoxiglucose F18 / Tomografia por Emissão de Pósitrons / Imagem Multimodal Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article